MRNA
Messenger ribonucleic acid (mRNA) is a single-stranded molecule of RNA that corresponds to the genetic sequence of a gene, and is read by a ribosome in the process of synthesizing a protein.
Recent news mentioning MRNA
- — If You'd Invested in Moderna (MRNA) Stock 5 Years Ago, Here's How Much You'd Have Today (Hint: You'd Be Disappointed -- But Not If You Bought It 1 Year Ago.)
- — Wall Street Has Cooled on Moderna After Its Stock Jumped Over 5X. But Does the mRNA Leader Have More Room to Run?
- — Jim Cramer Explains Why Heavily Shorted Moderna (MRNA) Has Room to Run
- — Moderna Rises 6% Despite GSK Moving Rival mRNA Flu Vaccine to Phase III
- — Jim Cramer Called Moderna Inc. (NASDAQ:MRNA) & Merck’s Trial Results Encouraging
- — Moderna (MRNA) Plans $2B of Zero-Coupon Convertible Debt. Is the Capped Call Enough to Control Dilution?
- — Jim Cramer Says Hold on to Moderna (MRNA) After Phase 3 Cancer Trial
- — Moderna (MRNA) & Merck (MRK): What’s Happening With These Two Stocks?
- — Moderna (MRNA), Merck (MRK) Cancer Vaccine Wins in Late-Stage Trial
- — Moderna Rallies 11%, BioNTech Ticks Up: Is the mRNA Trade Down to One Name?
- — Moderna (MRNA) Soars 179% as Melanoma Therapy Candidate Rewrites Growth Story
- — NVAX Stock Alert: Biotechs Hit Post-Pandemic High on mRNA Cancer Breakthrough